Day trading pre-market open November 24, page-26

EBR Systems IPO lists at 11am today.

EBR Systems’ WiSE technology is world’s first and only wireless, inside the left ventricle of the heart, pacing system for heart failure.

Strong competitive protection with 53 issued US patents and 44 issued patents outside the US.

WiSE awarded FDA Breakthrough Device Designation which provides greater interactive and timely communication with the FDA during the review process and initial multi-year payment coverage.

Highly experienced board and management with a track record in commercialising medical technology companies.

Existing investors, including, Brandon Capital, M.H. Carnegie & Co, Hostplus, TelstraSuper and HESTA contributed more A$30m of the funds raised under the offer.

Estimated addressable market of ~US$2.1b, growing to a market opportunity to ~US$7.1bn when extended to other patient groups.

Article: https://www.startribune.com/ebr-sys...th-a-device-powered-by-sound-waves/364684111/

Article: https://finance.yahoo.com/news/aussie-investor-love-affair-healthcare-033100509.html